Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.98 EUR | +0.62% | +0.48% | +24.97% |
05-22 | Health Care Up as Vaccine Makers Gain - Health Care Roundup | DJ |
05-22 | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
Sales 2024 * | 31.63B 40.24B 37.17B 3,163B | Sales 2025 * | 33.58B 42.73B 39.47B 3,358B | Capitalization | 72.94B 92.79B 85.72B 7,294B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 7.05B 6.52B 554B | Net income 2025 * | 6.49B 8.26B 7.63B 649B | EV / Sales 2024 * | 2.69 x |
Net Debt 2024 * | 12.29B 15.63B 14.44B 1,229B | Net Debt 2025 * | 9.07B 11.54B 10.66B 907B | EV / Sales 2025 * | 2.44 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.2
x | Employees | 70,212 |
Yield 2024 * |
3.41% | Yield 2025 * |
3.54% | Free-Float | 94.54% |
Latest transcript on GSK plc
1 day | +0.62% | ||
1 week | +0.48% | ||
Current month | +7.47% | ||
1 month | +10.76% | ||
3 months | +7.81% | ||
6 months | +28.86% | ||
Current year | +24.97% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 30/04/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
James Ford
CMP | Compliance Officer | - | 31/07/95 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
Jonathan Symonds
CHM | Chairman | 66 | 31/08/19 |
Hal Barron
BRD | Director/Board Member | 62 | 31/12/17 |
Date | Price | Change | Volume |
---|---|---|---|
22/05/24 | 20.85 | +2.16% | 0 |
21/05/24 | 20.41 | -0.92% | 992 |
20/05/24 | 20.6 | -2.32% | 0 |
17/05/24 | 21.09 | +2.78% | 2 |
16/05/24 | 20.52 | -1.11% | 6,900 |
Delayed Quote Deutsche Boerse AG, May 22, 2024 at 08:50 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+32.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.60% | 244B | |
+9.77% | 208B | |
-5.15% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock